Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.19 USD | -0.08% | -4.46% | +0.04% |
Financials (USD)
Sales 2024 * | 1.16B | Sales 2025 * | 1.25B | Capitalization | 12.16B |
---|---|---|---|---|---|
Net income 2024 * | 180M | Net income 2025 * | 226M | EV / Sales 2024 * | 10.6 x |
Net Debt 2024 * | 178M | Net cash position 2025 * | 16.78M | EV / Sales 2025 * | 9.73 x |
P/E ratio 2024 * |
69
x | P/E ratio 2025 * |
55.1
x | Employees | 3,050 |
Yield 2024 * |
0.41% | Yield 2025 * |
0.41% | Free-Float | 99.03% |
Latest transcript on Bio-Techne Corporation
1 day | -0.08% | ||
1 week | -4.46% | ||
1 month | +5.08% | ||
3 months | +3.78% | ||
6 months | +19.54% | ||
Current year | +0.04% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 57 | 18-04-29 |
James Hippel
DFI | Director of Finance/CFO | 53 | 14-03-31 |
Matthew McManus
COO | Chief Operating Officer | 55 | Jan. 07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 02-12-31 | |
Randolph Steer
BRD | Director/Board Member | 74 | 89-12-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 17-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.93% | 1 M€ | -.--% | - | |
2.50% | 5 M€ | -1.80% | - | |
2.15% | 2 M€ | -.--% | ||
1.25% | 0 M€ | 0.00% | - | |
1.13% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 77.19 | -0.08% | 1,307,031 |
24-05-30 | 77.25 | -1.72% | 1,222,601 |
24-05-29 | 78.6 | -1.00% | 718,496 |
24-05-28 | 79.39 | -1.73% | 795,261 |
24-05-24 | 80.79 | +0.47% | 452,637 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.04% | 12.16B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- TECH Stock